How Ascendis Pharma A/S stacks up

ASND · against 557 other Healthcare companies listed in US-listed

Profitability

15/ 100

Below the middle of the pack.

Ranked #388 of 558 · scores higher than 28% of peers

Bars: peers in each 10-point band of the profitability score

114 peers with a profitability score of 10–19, including ASND · Click a bar to see the companies

Why profitability scores 15?

Weighted metrics compared with all Healthcare companies.

Mainly because of its return on invested capital, return on assets and operating margin, which are weaker than most Healthcare peers.

a lower return on invested capital: weaker than 97% of peers. Return on invested capital: -300.9% vs peer median 4.7%
a lower return on assets: weaker than 79% of peers. Return on assets: -17.5% vs peer median 1.7%
a thinner operating margin: weaker than 77% of peers. Operating margin: -18.9% vs peer median 7.1%

Metric by metric

Position: dot = ASND, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.

Metric	ASND	Peer median	Better than	Weight
Return on invested capitalHigher is better · 517 reported	-300.9%	-7.0%	6%	33%
Operating marginHigher is better · 479 reported	-18.9%	-2.4%	39%	33%
Return on assetsHigher is better · 582 reported	-17.5%	-7.8%	40%	33%
Return on equityHigher is better · 531 reported	118.8%	-19.7%	99%	Context only
Gross marginHigher is better · 601 reported	91.3%	43.9%	91%	Context only

Ranking by profitability score

Top 5 and the companies ranked around ASND

Rank	Company	Market cap	Profitability	Overall
1	Arbutus Biopharma CorporationABUS · US-listed	595M USD	99	97
1	CorMedix Inc.CRMD · US-listed	433M USD	99	81
1	Exelixis, Inc.EXEL · US-listed	17.9B USD	99	76
1	IDEXX Laboratories, Inc.IDXX · US-listed	52.9B USD	99	57
1	Ironwood Pharmaceuticals, Inc.IRWD · US-listed	578M USD	99	73
⋯
376	Rhythm Pharmaceuticals, Inc.RYTM · US-listed	6.0B USD	16	32
376	Tyra Biosciences, Inc.TYRA · US-listed	1.5B USD	16	39
376	Zai Lab LimitedZLAB · US-listed	2.5B USD	16	31
388	Armata Pharmaceuticals, Inc.ARMP · US-listed	115M USD	15	8
388	Ascendis Pharma A/SASND · US-listed	16.5B USD	15	37
388	ArriVent BioPharma, Inc.AVBP · US-listed	642M USD	15	46
388	Butterfly Network, Inc.BFLY · US-listed	1.7B USD	15	30
388	Bionano Genomics, Inc.BNGO · US-listed	17M USD	15	18
388	ClearPoint Neuro, Inc.CLPT · US-listed	296M USD	15	26

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…